Morgan Stanley Maintains Equal-Weight on Stride, Lowers Price Target to $95
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Greg Parrish maintains Stride (NYSE:LRN) with a Equal-Weight and lowers the price target from $130 to $95.
Morgan Stanley analyst Greg Parrish maintains Stride (NYSE:LRN) with a Equal-Weight and lowers the price target from $130 to $95.